about
Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesMethylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patientsAntitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models.Epigenetic remodelling of gene expression profiles of neoplastic and normal tissues: immunotherapeutic implicationsEpigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.Epigenetics of melanoma: implications for immune-based therapies.Epigenetics meets immune checkpoints.Immunomodulatory activity of SGI-110, a 5-aza-2'-deoxycytidine-containing demethylating dinucleotide.Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome.Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy.Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention5-AZA-2'-Deoxycytidine in Cancer Immunotherapy: A Mouse to Man StoryCirculating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival
P50
Q33980682-44C5DF2D-FFE7-4ACC-AD12-EB3915F89F05Q35069309-0DCC1E54-84DA-4831-998C-C86D89FCF53EQ36060324-89B50A67-521B-499D-A0BC-CCD1F0E00D0BQ36287972-8940430B-8BD6-4303-9DB5-D6DEDDDCE345Q36801625-EEC5C6A8-DF18-407B-8D10-798EDEDE52A4Q38148588-379909F0-3519-4F6D-B538-B303E2D61F62Q38475156-05AAABEB-CDDE-414B-B7CA-6CF839E7722EQ39247530-552A9351-AFCA-4A3D-A79D-7BF6A8D0CC61Q39500230-32AEB074-C69D-48A8-B905-5A7D460249A4Q43176112-9BB3AB7B-B706-4B4E-8380-288DD1A7EDDCQ45284162-1E117F61-59A8-47FF-AC9F-9AD8974A691BQ46047090-49455B1D-8D89-4EA3-ADFA-E89E5E501E35Q57570326-43D33536-F9A0-4F0A-B2C3-B4DBAE52283FQ57570355-346C176B-DF1D-44FF-8240-1C5866246E13Q89598354-37A2FD27-6F5B-4C62-BB09-3A20AC96F73A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alessia Covre
@ast
Alessia Covre
@en
Alessia Covre
@es
Alessia Covre
@nl
type
label
Alessia Covre
@ast
Alessia Covre
@en
Alessia Covre
@es
Alessia Covre
@nl
prefLabel
Alessia Covre
@ast
Alessia Covre
@en
Alessia Covre
@es
Alessia Covre
@nl
P106
P1153
16199701000
P31
P496
0000-0001-8721-5693